Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium.

about

Analysis of Runx1 Using Induced Gene Ablation Reveals Its Essential Role in Pre-liver HSC Development and Limitations of an In Vivo Approach

P2860

Q57580487-0B8F48B6-FD48-4E9D-BE65-F980998A87A3

P2860

Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium.

Item

http://www.wikidata.org/entity/Q55279547

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Regulation of RUNX1 dosage is ...... on from hemogenic endothelium.

@en

Regulation of RUNX1 dosage is ...... on from hemogenic endothelium.

@nl

type

Item

label

Regulation of RUNX1 dosage is ...... on from hemogenic endothelium.

@en

Regulation of RUNX1 dosage is ...... on from hemogenic endothelium.

@nl

prefLabel

Regulation of RUNX1 dosage is ...... on from hemogenic endothelium.

@en

Regulation of RUNX1 dosage is ...... on from hemogenic endothelium.

@nl

P1476

Regulation of RUNX1 dosage is ...... ion from hemogenic endothelium

@en

P2093

Andrew J Lilly

http://www.w3.org/2001/XMLSchema#string

Mairi Challinor

http://www.w3.org/2001/XMLSchema#string

Michael Lie-A-Ling

http://www.w3.org/2001/XMLSchema#string

Rahima Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Genome engineering using the CRISPR-Cas9 system

Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis

Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia

Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation

The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage

Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor

A third-generation lentivirus vector with a conditional packaging system

Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles.

P31

scholarly article

P356

10.1242/DEV.149419

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

145

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29530939

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

P932

5868988

http://www.w3.org/2001/XMLSchema#string

Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium.

about

P2860

P2860

Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932